Skip to search formSkip to main contentSkip to account menu

Eperzan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
LE MÉDICAMENT DU MOIS L'albiglutide (Eperzan ® ) : nouvel agoniste des récepteurs du glucagon-like peptide-1 en injection hebdomadaire
Rev Med Liège 2015; 70 : 4 : 207-214 Résumé : L’albiglutide (Eperzan) est un nouvel agoniste des récepteurs du Glucagon-Like… 
Review
2015
Review
2015
[Albiglutide (Eperzan): a new once-weekly agonist of glucagon-like peptide-1 receptors].
Albiglutide (Eperzan) is a new once-weekly agonist of Glucagon-Like Peptide-1 (GLP-1) receptors that is indicated in the… 
2015
2015
[Albiglutide (Eperzan): a new once-weekly agonist of glucagon-like peptide-1 receptors].
Abstract Albiglutide (Eperzan) is a new once-weekly agonist of Glucagon-Like Peptide-1 (GLP-1) receptors that is indicated in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)